REVLIMID 25 mg, Hartkapseln - 21 Kapsel(n) Swissmedic Key 57712004 Registration Holder Bristol-Myers Squibb SA Name REVLIMID 25 mg, Hartkapseln Date of registration 29.08.2007 Original/Generic Original Introduction of Sequence 29.08.2007 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 21 Kapsel(n) Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 2870.45 Limitation Yes Limitation text
Deductible 20 % Consumer price 3014.50 Feedback FB Daily cost GTIN 7680577120047 Medication Code Synthetika Pharmacode 3542322 Disponibility
Composition lenalidomidum 25 mg, lactosum 200 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.8 mg, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 25 mg
BAG: Active Agent Dose Lenalidomidum 25 mg
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 200 mg Magnesii Stearas Pro Capsula Propylenglycol
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :